A powerful big data platform for clinical and drug discovery researchers supporting cohort and clinical genome analysis.
Big Data in the medical field is expected to be a powerful technology for the creation of new medical technologies. The BaseSpace Cohort Analyzer is a groundbreaking Medical Big Data system that can search clinical data, treatment histories, and various omics data for various cancer patients and autoimmune patients, and further study the effects of drugs tailored to patient characteristics using various analytical tools. Additionally, information from Observational Studies is utilized in the latest medical settings for early diagnosis and personalized medicine. The BaseSpace Cohort Analyzer can search clinical data, treatment histories, and various omics data for various cancer patients and autoimmune patients, and further elucidate the mutations and dynamics of genes that cause diseases, providing treatment advice.
Inquire About This Product
basic information
Cohort Analyzer is an analysis platform that operates in the cloud using a standard browser, allowing for easy access and use from anywhere. Additionally, enterprises and large research institutions can utilize an Enterprise license platform that enables automated analysis using APIs and the sharing of imported data among multiple users to create a personal database. For users seeking basic analysis, we offer a Correlation Engine license. *For more details, please refer to the catalog or feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
[Uses] - Drug discovery - Clinical research - Basic research
catalog（3）
Download All Catalogs
Company information
Our company was established in 2005 and is engaged in the sale of software and databases related to biotechnology and chemicals, the construction and consulting of drug discovery informatics systems, and consulting and data contract analysis for bio-related businesses. Our mission is to provide researchers involved in bio-related studies at universities and public research institutions, as well as those engaged in new drug development at pharmaceutical companies and medical professionals working in hospitals, with useful information, technology, and services at the optimal timing they require for their research.